• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVRx, Inc. - Common Stock (NQ:CVRX)

6.920 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CVRx, Inc. - Common Stock

News headline image
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 17, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
March 17, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 17, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
March 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
February 24, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
February 19, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
February 19, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
February 19, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
February 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.
February 10, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
February 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm
January 30, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
January 29, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRX
January 27, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
February 12, 2025
New real-world evidence presented at THT 2025 and published simultaneously in the Journal of Cardiac Failure (JCF) demonstrates large and statistically significant reductions in hospital visits and... 
From CVRx, Inc.
Via GlobeNewswire
News headline image
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
February 04, 2025
From CVRx, Inc.
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm
August 26, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx, Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm
August 08, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 08, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
CVRX Investors Have Opportunity to Join CVRx, Inc. Fraud Investigation with the Schall Law Firm
August 03, 2024
From The Schall Law Firm
Via Business Wire
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies CVRx, Inc. (CVRX) Investors of Investigation
February 23, 2023
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
December 20, 2022
From CVRx, Inc.
Via GlobeNewswire
News headline image
CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
November 03, 2022
From CVRx, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap